Neoadjuvant therapy in breast cancer: can we define its role?
about
Regulation of mitosis and taxane response by Daxx and Rassf1.ERCC1 polymorphisms as prognostic markers in T4 breast cancer patients treated with platinum-based chemotherapyPrediction of pathological complete response of breast cancer patients undergoing neoadjuvant chemotherapy: usefulness of breast MRI computer-aided detectionInflammatory breast cancer: is it really a separate entity?Measurement of volumetric and vascular changes with dynamic contrast enhanced MRI for cancer therapy monitoring.
P2860
Neoadjuvant therapy in breast cancer: can we define its role?
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Neoadjuvant therapy in breast cancer: can we define its role?
@ast
Neoadjuvant therapy in breast cancer: can we define its role?
@en
Neoadjuvant therapy in breast cancer: can we define its role?
@nl
type
label
Neoadjuvant therapy in breast cancer: can we define its role?
@ast
Neoadjuvant therapy in breast cancer: can we define its role?
@en
Neoadjuvant therapy in breast cancer: can we define its role?
@nl
prefLabel
Neoadjuvant therapy in breast cancer: can we define its role?
@ast
Neoadjuvant therapy in breast cancer: can we define its role?
@en
Neoadjuvant therapy in breast cancer: can we define its role?
@nl
P1433
P1476
Neoadjuvant therapy in breast cancer: can we define its role?
@en
P2093
P356
10.1634/THEONCOLOGIST.6-SUPPL_3-36
P478
P577
2001-01-01T00:00:00Z